A B S T R A C T The secretion of androgens and estrogens by normal and abnormal testes was compared by determining the concentrations of dehydroepiandrosterone (DHEA), androstenedione (A4A), testosterone (T), estrone (El), and 17f-estradiol (E2) in peripheral and spermatic venous plasma samples from 14 normal men and 5 men with unilateral testicular atrophy. Four normal men and one patient with unilateral atrophy of the testis were given human chorionic gonadotropin (HCG) before surgery. Plasma estrogens were determined by radioimmunoassay; plasma androgens were measured by the double-isotope dilution derivative technique. Peripheral concentrations of these steroids before and after HCG were similar in both the normal men and the patients with unilateral testicular atrophy. In normal men, the mean +SE spermatic venous concentrations were DHEA, 73.1±+11.7 ng/ml; A4A, 30.7±7.9 ng/ml; T, 751±114 ng/ml; Ei, 306±55 pg/ml; and Ea, 1298±216 pg/ml. Three of four subjects with unilateral testicular atrophy had greatly diminished spermatic venous levels of androgens and estrogens. HCG treatment increased In the single subject with an atrophic testis who received HCG, the spermatic venous concentrations of androgens and estrogens were much less than in normal men similarly treated. We conclude that: (a) El is secreted by the human testis, but testicular secretion of El accounts for less than 5% of El production in normal men; (b) HCG stimulation produces increases in spermatic venous estrogens equal to or greater than the changes in androgens, including testosterone; and (c) strikingly decreased secretion of androgen and estrogen by unilateral atrophic human testes cannot be appreciated by analyses of peripheral steroid concentrations.
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INTRODUCTION
Secretion of 17p8-estradiol (E2)' by the human testis has recently been documented and compared to the secretion of testosterone (1) Tables  I and II) in 14 normal adults. Four subjects received intramuscular HCG before surgery: three 5,000 U/day for 4 days and one 5,000 U/day for 2 days. For comparison, five additional subjects with unilateral testicular atrophy (testis less than 3.0 cm in greatest diameter) were similarly studied during an elective inguinal her-niorrhaphy on the side of the atrophic testis. One of these subjects (patient 19, Tables III and IV) also received HCG (5,000 U/day for 4 days) before surgery. Spermatic venous blood was collected as previously described (1) . Informed consent was obtained from all subjects.
Steroid analyses. Plasma levels of DHEA, A4A, and T were determined by a modification (2) of the doubleisotope dilution derivative technique combined with gasliquid chromatography (3) . Plasma concentrations of E2 and E1 were performed by radioimmunoassay. The details of our initial assay of E2 and the modifications in methodology for simultaneous measurement of plasma E1 and Es have been described in detail (1, 4) . Duplicate determinations of an adult female plasma pool (10 assays) averaged 87±8.6 (SD) pg/ml for E1 and 123±14.1 (SD) pg/ml for E2. The concentrations of El and E2 in spermatic venous plasma were determined at four or more different dilutions to ensure parallelism with the standards.
The cross-reactivity of nonphenolic Cio and Cn steroids is negligible in both E1 and E2 radioimmunoassays. For example, T shows 0.001% cross-reactivity in the El assay and less than 0.001% in the E2 assay. In addition, the Sephadex LH-20 chromatographic system used in the estrogen assays reliably separates C19 and C2, plasma steroids from the E1 and E. fractions (4 40±5) (4). The concentrations of E2 in peripheral plasma agree with values previously reported by us (1, 4) and others (9, 11, 12) . Spermatic venous E1 concentrations ranged from 135 pg/ml to 665 pg/ml. Concentrations of spermatic venous E2 are slightly higher than in our previous report (1) . This increase, similar to the changes in DHEA, was influenced greatly by subjects 3, 4, and 7. Concentrations of spermatic venous E2 were approximately fourfold greater than spermatic venous Ei levels. HCG, in subjects 11, 12, and 13, produced a slight increase in peripheral venous E1 but a greater, approximately threefold, increase in E2, while testicular gradients (spermatic minus peripheral) of E1 and E2 increased six-and eightfold, respectively. In subject 14 after only 2 days of HCG, four-and sixfold increases, respectively, in testicular gradients of E1 and E2 were observed.
Abnormal human testis Androgen secretion before and after HCG. Table III lists the peripheral and spermatic venous concentrations of DHEA, A4A, and T in five subjects, each with an atrophic testis. Peripheral DHEA, AA, and T were normal. Spermatic venous DHEA, A4A, and T were markedly reduced in three subjects, 15, 16, and 17, while levels in subject 18 were normal. After HCG, a normal increase in the peripheral concentrations of DHEA, A4A, and T was found in subject 19. However, the spermatic venous concentrations of DHEA, A4A, and T were much less than in normal men treated with HCG. Table IV lists the peripheral and spermatic venous E1 and E2 concentrations in five subjects, each with an atrophic testis. Peripheral concentrations of E1 and E2 were normal. Like the concentrations of androgens, spermatic venous concentrations of El and E2 were strikingly reduced in subjects 15, 16, and 17. In subject 18, E1 and E2 spermatic venous concentrations were lownormal. In subject 19, the spermatic venous concentrations of El and E2 were much less than the levels found in normal men similarly treated with HCG; however, HCG produced a normal rise in peripheral E1 and E2.
DISCUSSION
The concentrations of unconjugated androgens and estrogens in peripheral and spermatic venous plasma have been compared in men with normal and abnormal testes before and after HCG. In normal subjects concentrations of unconjugated A4A and T in spermatic venous plasma Laatikainen et al. (6) . However, the concentration of DHEA in spermatic venous plasma was higher. This difference can be explained, in part, by the remarkably high values in subjects 3, 4, and 7. After HCG, peripheral levels of DHEA and A4A increased 50% or less, while spermatic venous concentrations increased five-and threefold, respectively. Since the major source of these steroids is adrenal and not testicular, the small increase in peripheral plasma values would be expected.
Recently secretion of E2 by the normal human testis was established (1, 13) , which allowed us to estimate that testicular secretion of E2 accounts for at least onefourth of E2 production (1) . We now present direct evidence for the testicular secretion of E1 with a testicular E1 gradient of 245 pg/ml. Utilizing the mean blood production rate of T, 7 mg/day for normal adult males (14) , and the experimentally determined T and EB gradients from this study, we estimate testicular E1 secretion to be 2.5 ug/day.. A comparison of this estimate with calculated production rates of El (45 /Ag/day-80 t'g/day) (15, 16) indicates that testicular secretion accounts for less than 5% of E1 production in normal men. Thus, nearly all of E1 production is by peripheral hormonal interconversions (17, 18) and extratesticular secretion (19 After HCG, spermatic venous E1 and E2 increased strikingly: El, sixfold; and E2, eightfold. These responses were equal to or greater than changes observed in any of the androgens, including T. The slight increase in the peripheral concentrations of E1 after HCG support our conclusion that the major sources of El are nontesticular. In contrast, the larger rise in peripheral E2 after HCG (fourfold) also indicates that the testicular secretion of E2 is greater than E1.
Spermatic venous concentrations of unconjugated androgens and estrogens in three subjects, 15, 16, and 17, with unilateral testicular atrophy were significantly reduced. The normal peripheral levels in these subjects suggest that the contralateral testis had compensated by secretion of greater than normal amounts of androgens and estrogens. The low values found in the spermatic venous samples in HCG-stimulated and untreated patients with unilateral atrophic testes (four of five) indicate that hormone secretion and secretory reserve are limited in these instances.
Although comparisons between the subjects in this study (treated vs. untreated and normal vs. atrophic testes) seem valid, unqualified extrapolation of these data to the normal state is unwarranted. For example, surgical stress has been shown to decrease plasma T in men (cf. peripheral T values in subjects 1 and 3) (21) . Further, the effects of anesthesia on testicular blood flow and on metabolic clearance of unconjugated steroids are unclear.
